Class II but Not Second Class-Prospects for the Development of Class II PI3K Inhibitors.

Mountford, Simon J; Zheng, Zhaohua; Sundaram, Krithika; Jennings, Ian G; Hamilton, Justin R; Thompson, Philip E.

Afiliación

Mountford SJ; Medicinal Chemistry, Monash Institute of Pharmaceutical Sciences, Monash University (Parkville Campus) , 381 Royal Parade, Parkville, Victoria 3052, Australia.
Zheng Z; Medicinal Chemistry, Monash Institute of Pharmaceutical Sciences, Monash University (Parkville Campus) , 381 Royal Parade, Parkville, Victoria 3052, Australia ; Australian Centre for Blood Diseases and Department of Clinical Haematology, L6, Monash University , 89 Commerical Road , Prahran, Victoria
Sundaram K; Medicinal Chemistry, Monash Institute of Pharmaceutical Sciences, Monash University (Parkville Campus) , 381 Royal Parade, Parkville, Victoria 3052, Australia.
Jennings IG; Medicinal Chemistry, Monash Institute of Pharmaceutical Sciences, Monash University (Parkville Campus) , 381 Royal Parade, Parkville, Victoria 3052, Australia.
Hamilton JR; Australian Centre for Blood Diseases and Department of Clinical Haematology, L6, Monash University , 89 Commerical Road , Prahran, Victoria 3181, Australia.
Thompson PE; Medicinal Chemistry, Monash Institute of Pharmaceutical Sciences, Monash University (Parkville Campus) , 381 Royal Parade, Parkville, Victoria 3052, Australia.

ACS Med Chem Lett ; 6(1): 3-6, 2015 Jan 08.

Article en En | MEDLINE | ID: mdl-25589915